An FGFR4 polymorphism is implicated in the progression of neuroendocrine tumors

被引:0
|
作者
Serra, S. [1 ]
Zheng, L. [1 ]
Chetty, R. [1 ]
Ezzat, S. [1 ]
Asa, S. L. [1 ]
机构
[1] UHN, Dept Pathol, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:41 / 41
页数:1
相关论文
共 50 条
  • [31] FGFR3 and FGFR4 mutational analyses in thyroid carcinoma
    Serra, S.
    Cheng, S.
    Ezzat, S.
    Asa, S. L.
    MODERN PATHOLOGY, 2008, 21 : 110A - 111A
  • [32] Exploring the involvement of FGFR4 in hepatocellular carcinoma
    Ho, Han Kiat
    Pok, Sharon
    Ruhe, Jens E.
    Hart, Stefan
    Streit, Sylvia S.
    Loo, Hooi Linn
    Foo, Priscilla
    Do Aung, Myat
    Ullrich, Axel
    Lim, Seng Gee
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3549S - 3550S
  • [33] Targeting FGFR4 in colorectal cancer cells
    Heinzle, Christine
    Erdem, Zeynep
    Sonvilla, Gudrun
    Staettner, Stefan
    Karner, Josef
    Klimpfinger, Martin
    Grasl-Kraupp, Bettina
    Holzmann, Klaus
    Grusch, Michael
    Berger, Walter
    Marian, Brigitte
    CANCER RESEARCH, 2012, 72
  • [34] FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men
    C K M Ho
    S Anwar
    J Nanda
    F K Habib
    Prostate Cancer and Prostatic Diseases, 2010, 13 : 94 - 96
  • [35] FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients
    S Streit
    D S Mestel
    M Schmidt
    A Ullrich
    C Berking
    British Journal of Cancer, 2006, 94 : 1879 - 1886
  • [36] Fibroblast growth factor receptor 4 (FGFR4) G388R polymorphism in colorectal cancer
    Heinzle, C.
    Hunjadi, M.
    Erdem, Z.
    Staettner, S.
    Klimpfinger, M.
    Grasl-Kraupp, B.
    Holzmann, K.
    Grusch, M.
    Berger, W.
    Marian, B.
    EJC SUPPLEMENTS, 2010, 8 (07): : 108 - 108
  • [37] FGFR4 Splice Variants in Adrenocortical Carcinomas
    Furlan, Karina
    Boyle, Theresa
    Saeed-Vafa, Daryoush
    LABORATORY INVESTIGATION, 2023, 103 (03) : S487 - S487
  • [38] Involvement of FGFR4 in Pulmonary Fibrosis Pathophysiology
    Ghanem, M.
    Justet, A.
    Jaillet, M.
    Hachem, M.
    Boghanim, T.
    Vadel, A.
    Mailleux, A.
    Crestani, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [39] NVP-FGF401: Cellular and in vivo profile of a novel highly potent and selective FGFR4 inhibitor for the treatment of FGF19/FGFR4/KLB+ tumors
    Weiss, Andreas
    Porta, Diana Graus
    Reimann, Flavia
    Buhles, Alexandra
    Stamm, Christelle
    Fairhurst, Robin A.
    Kinyamu-Akunda, Jacqueline
    Sterker, Dario
    Murakami, Masato
    Wartmann, Markus
    Wang, Youzhen
    Engelman, Jeffrey A.
    Hofmann, Francesco
    Sellers, Wiliam R.
    CANCER RESEARCH, 2017, 77
  • [40] Cancer progression and tumor cell motility are associated with the FGFR4 Arg388 allele
    Bange, J
    Prechtl, D
    Cheburkin, Y
    Specht, K
    Harbeck, N
    Schmitt, M
    Knyazeva, T
    Müller, S
    Gärtner, S
    Sures, I
    Wang, HY
    Imyanitov, E
    Häring, HU
    Knayzev, P
    Iacobelli, S
    Höfler, H
    Ullrich, A
    CANCER RESEARCH, 2002, 62 (03) : 840 - 847